Skip to content

Comparison of Dexamethasone- Ketamine and Dexmedetomidine ?for prevention of postoperative nausea and vomiting during and ?after cesarean section under spinal anesthesia

Comparison of Dexamethasone- Ketamine and Dexmedetomidine ?for prevention of postoperative nausea and vomiting during and ?after cesarean section under spinal anesthesia

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016091320258N10
Enrollment
120
Registered
2016-11-08
Start date
2017-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean. Single delivery by caesarean section

Interventions

Intervention 1: We injected 20? milliliter normal saline in first group. Intervention 2: We injected 8 milligram of ?Dexamethasone in 20 ml of normal ??saline in second group. Intervention 3: We injec
Treatment - Drugs
We injected 20? milliliter normal saline in first group
We injected 8 milligram of ?Dexamethasone in 20 ml of normal ??saline in second group.
We injected ??0/5 milligram in Ketamine in 20 milliliter ?normal ?saline in 10 minute in third group.
We injected 1 microgram per ?kilogeram of Dexmedetomidine in ??20 milliliter of ?normal ?saline in 10 minute in fourth group.

Sponsors

Vice chancellor for research, Arak University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: single pregnancy; 18 -35 years; elective cesarean section; ASA ?I,II Exclusion criteria: general anesthesia; prescription drugs after delivery; body ?mass index more than 35; motion sickness; Intrauterine growth retardation; ?history of anti-nausea and vomiting 24 hours before surgery; history of ?gastrointestinal disease; history of allergy; Nausea and vomiting before ?clamping the umbilical cord; lack of patient satisfaction.?

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nausa and vomitting. Timepoint: After clamping the umbilical cord ?. Method of measurement: Visual Analogue Scale.;Blood pressure. Timepoint: Every 5 minute to recovery. Method of measurement: Millimeter Hg.;Heart rate. Timepoint: Every 5 minute to recovery. Method of measurement: Count.;Oxygen saturation. Timepoint: Every 5 minute to recovery. Method of measurement: Percent.;Patient satisfaction ?. Timepoint: After recovery. Method of measurement: Visual Analogue Scale.;Total of dose of Metoclopramide. Timepoint: After recovery. Method of measurement: Miligeram.;Degree of patient peace ?. Timepoint: Before prescribe to after recovery. Method of measurement: Ramsay Scale? ?.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNilufar Shams

Medicine department

alikamaliir@yahoo.com+98 86 3417 3638

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026